Tylenol autism lawsuits revived against Kenvue
Kenvue faces renewed litigation risk and potential liability after a federal appeals court revived over 500 lawsuits linking Tylenol to neurodevelopmental disorders.
The argument
The court ruled that a trial judge erred in excluding the plaintiffs' expert medical witnesses who associate acetaminophen use during pregnancy with ADHD or autism. This decision sends the case back to a lower court, complicating Kimberly Clark's pending $40 billion acquisition of Kenvue.
The thesis, stress-tested
✓ What validates it
- ✓Lower court rulings on the admissibility or strength of the plaintiffs' expert testimony
- ✓Developments or renegotiations in Kimberly Clark's planned acquisition of Kenvue
▸ Risks discussed
- ▸A lack of proven scientific consensus linking acetaminophen to ADHD or autism
- ▸The lower court potentially ruling in favor of Kenvue on other grounds
Hear it yourself
"And a federal appeals court has revived more than 500 lawsuits that alleged Tylenol and generic acetaminophen can cause ADHD or autism. The court ruled that a trial judge had overstepped by excluding the plaintiff's expert medical witnesses."
00:00 / 00:16
AFFILIATE LINK · ZORTIX MAY EARN A COMMISSION · NEVER A RECOMMENDATION TO TRADE